Blue Bell Private Wealth Management’s VanEck Pharmaceutical ETF PPH Stock Holding History

Blue Bell Private Wealth Management’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-78	Closed	-$7.11K	–	754
2025 Q1	$7.11K	Hold	78	–	–	﹤0.01%	541
2024 Q4	$6.73K	Hold	78	–	–	﹤0.01%	530
2024 Q3	$7.41K	Hold	78	–	–	﹤0.01%	544
2024 Q2	$7.13K	Hold	78	–	–	﹤0.01%	547
2024 Q1	$7.08K	Hold	78	–	–	﹤0.01%	547
2023 Q4	$6.35K	Hold	78	–	–	﹤0.01%	541
2023 Q3	$6.23K	Hold	78	–	–	﹤0.01%	479
2023 Q2	$6.14K	Hold	78	–	–	﹤0.01%	477
2023 Q1	$6.05K	Hold	78	–	–	﹤0.01%	441
2022 Q4	$6.06K	Hold	78	–	–	﹤0.01%	436
2022 Q3	$5K	Hold	78	–	–	﹤0.01%	477
2022 Q2	$6K	Hold	78	–	–	﹤0.01%	480
2022 Q1	$6K	Hold	78	–	–	﹤0.01%	531
2021 Q4	$6K	Buy	+78	New	+$5.8K	﹤0.01%	502

Other funds holding PPH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Avalon Trust Santa Fe, New Mexico $1.45B AUM 35.31% 1-Year Est. Return

JSAM

J. Safra Asset Management New York $1.86B AUM 22.95% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

AWC

Adamsbrown Wealth Consultants Wichita, Kansas $530M AUM 23.21% 1-Year Est. Return

Blue Bell Private Wealth Management's PPH Position: Q2 2025 in Review

Blue Bell Private Wealth Management sold out of VanEck Pharmaceutical ETF (PPH) in Q2 2025, closing a stake of 78 shares — an estimated $7.11K sold.

Blue Bell Private Wealth Management first reported a position in PPH in Q4 2021 and held it in 14 quarters. The position peaked at $7.41K in Q3 2024. 129 funds tracked by Wall St. Rank hold PPH as of Q2 2025.

Blue Bell Private Wealth Management reported no remaining VanEck Pharmaceutical ETF position as of Q2 2025 after selling out during the quarter.
Blue Bell Private Wealth Management sold 78 VanEck Pharmaceutical ETF shares in Q2 2025, an estimated $7.11K.
Blue Bell Private Wealth Management first reported a position in VanEck Pharmaceutical ETF in Q4 2021 and held it in 14 quarters.
Blue Bell Private Wealth Management's VanEck Pharmaceutical ETF position peaked at $7.41K in Q3 2024.
129 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2025.

Based on Blue Bell Private Wealth Management's 13F filing for Q2 2025, filed 11 Aug 2025.